Molecular Characterization of IDH Wild-type Diffuse Astrocytomas: The Potential of cIMPACT-NOW Guidelines-Reference-Cited by-同舟云学术

Molecular Characterization of IDH Wild-type Diffuse Astrocytomas: The Potential of cIMPACT-NOW Guidelines

Published:2022-06-17 Issue:6 Volume:30 Page:410-417
ISSN:1541-2016
Container-title:Applied Immunohistochemistry & Molecular Morphology
language:en
Short-container-title:

Author:

Kumari Kalpana,Dandapath Iman,Singh Jyotsna,Rai Hitesh I.S.,Kaur Kavneet,Jha Prerana,Malik Nargis,Chosdol Kunzang,Mallick Supriya,Garg Ajay,Suri Ashish,Sharma Mehar C.,Sarkar Chitra,Suri Vaishali

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Medical Laboratory Technology,Histology,Pathology and Forensic Medicine

Reference33 articles.

1. cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV”;Brad;Acta Neuropathol,2018

2. cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading;Louis;Brain Pathol,2020

3. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary;Louis;Neuro Oncol,2021

4. The 2016 World Health Organization of Tumors of the Central Nervous System: a summary;Louis;Acta Neuropathol,2016

5. Molecular and clinical heterogeneity of adult diffuse low-grade IDH wild-type gliomas: assessment of TERT promoter mutation and chromosome 7 and 10 copy number status allows superior prognostic stratification;Wijnenga;Acta Neuropathol,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing the risk stratification of astrocytic tumors by applying the cIMPACT-NOW Update 3 signature: real-word single center experience;Scientific Reports;2023-11-16

2. IDH wild-type lower-grade gliomas with glioblastoma molecular features: a systematic review and meta-analysis;Brain Tumor Pathology;2023-05-22